Menu

Recent Interviews

Dirk Graszt, CEO, Clean Logistics SE

Dirk Graszt
CEO | Clean Logistics SE
Trettaustr.32, 21107 Hamburg (DE)

info@cleanlogistics.de

+49-4171-6791300

Interview Clean Logistics: Hydrogen challenge to Daimler + Co.


Matthew Salthouse, CEO, Kainantu Resources

Matthew Salthouse
CEO | Kainantu Resources
3 Phillip Street #19-01 Royal Group Building, 048693 Singapore (SGP)

info@krl.com.sg

+65 6920 2020

Interview Kainantu Resources: "We hold the key to growth in the Asia-Pacific region".


Justin Reid, President and CEO, Troilus Gold Corp.

Justin Reid
President and CEO | Troilus Gold Corp.
36 Lombard Street, Floor 4, M5C 2X3 Toronto, Ontario (CAN)

info@troilusgold.com

+1 (647) 276-0050

Interview Troilus Gold: "We are convinced that Troilus is more than just a mine".


30. October 2020 | 09:37 CET

BioNTech, Newlox Gold, NEL ASA - get in now!

  • Investments
Photo credits: pixabay.com

Germany in a state of shock! After the announcement of a second lockdown and a steadily increasing number of infections, the calls for a vaccine against coronavirus are getting louder and louder. The question is not when, but how quickly it will be available, especially for risk groups. Three Companies are currently heading for the home stretch. The first mover will not only get fame and recognition, but the market value of the Company will go through the roof. After the strong sell-off on the world's stock markets, there are lucrative entry opportunities.

time to read: 2 minutes by Stefan Feulner
ISIN: CA65151R1001 , US09075V1026 , NO0010081235


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


BioNTech in the pole position

The British Times reported on Wednesday, citing government circles, that the Mainz-based BioNTech could distribute a vaccine before Christmas. This outcome would enable BioNTech and its partner, Pfizer, to outdo the tough competition from the British Company, Astra Zeneca and the US Company, Moderna. Even if it is "only" a lead of two weeks, this will correlate with the assumed positive study results.

Pfizer boss sticks to schedule

Albert Bourda, CEO of Pfizer, recently announced that the Company would apply for emergency approval of its corona vaccine in the United States in November. The FDA approval is conditional on efficacy and safety data being positive in ongoing trials. The US biotech company, Moderna, does not intend to apply for emergency approval until December. After the positive news, BioNTech's share price rose yesterday by over 8% to USD 84.00. The shares were trading at USD 76.00 the day before due to strong selling in the overall market. The high was USD 94.00. If the results remain positive, new highs may only be a matter of time.

The Green Gold

First Mover status has already been achieved by Canadian junior gold production and environmental Company, Newlox Gold Ventures Corp., in the area of sustainably mined gold. The strategy was born by chance. "We were shocked when the results came back from the lab showing that the tailings had a higher grade than the mine plan we were developing at the time..." CEO Ryan Jackson told us in an interview. The reason for the high grade in the tailings was due to decades of artisanal processing, which is only 40% effective in extracting gold.

New focal points set new standards

Newlox Gold, in collaboration with the Norman B. Keevil Institute of Mining Engineering at the University of British Columbia, has developed a customized system for recovering precious metals from artisanal tailings piles, while at the same time carrying out environmental remediation. Artisanal gold accounts for 20% of global gold production. It is a USD 27 billion industry that has been completely neglected by traditional mining companies. The current market capitalization is just CAD 15 million. Newlox has access to 30 historic, prospective gold projects. The fact that Canadians are paying attention to environmental and social aspects is setting new standards, especially in the gold mining industry.

Disappointing stock market debut

The Norwegian hydrogen Company, NEL ASA, is not doing well with partnerships and participations at the moment. The disaster around Nikola, a US fuel cell and battery truck builder, which has been burdened with severe fraud allegations, was already one of the main topics on the capital market this summer. Yesterday came the next, admittedly minor disappointment. The Danish hydrogen Company, Everfuel, celebrated its IPO. NEL ASA still holds 19.9% of the Company, which was spun off in 2019. The placement price was still at NOK 22. However, during the meeting, the price dropped to as low as NOK 15. Considering that hydrogen shares are all the rage at the moment, a bitter disappointment. On the positive side, the Danes were able to place shares worth almost NOK 27 million in a private placement for NOK 22.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. October 2021 | 12:10 CET | by Carsten Mainitz

Formycon, Memiontec, Synlab - Act before it is too late!

  • Investments

When an unpredictable event occurs, humanity sees how powerless it is in the face of it. We saw this in the spring of last year with the outbreak of the Corona pandemic. Only since the approval of various vaccines has a normalization taken place. However, further, foreseeable problems are coming our way. According to expert forecasts, water demand will exceed supply by 40% as early as 2030. Some companies sense an opportunity to profit from the water shortage through novel technologies.

Read

14. October 2021 | 07:46 CET | by Stefan Feulner

SAP, Kleos Space, Ballard Power - Igniting like a rocket

  • Investments

The storage and processing of data will be one of the themes of our society for the coming years. Big Data will create scientific advances and innovations, increasing the competitiveness of both science and companies across industries. Already today, innovative startups are working on the processing of larger amounts of data using artificial intelligence. The potential is enormous, the predicted growth rates gigantic.

Read

11. October 2021 | 11:30 CET | by Armin Schulz

Allianz, wallstreet:online, Commerzbank - Quo vadis stock markets?

  • Investments

The markets are highly nervous at the moment. First, the Corona numbers went up again, then the Chinese real estate giant Evergrande was on the verge of collapse, and the supply chains are still not back in step. The result was falling indexes. That automatically leads to more fear, as the Fear and Greed Index also showed. Last week, the market calmed down slightly, and the fear index dropped from 27 to 34 points. In Germany, there is also the fact that more people have dabbled in equity investments due to a lack of interest rates. According to the Global Wealth Report, the purchase of securities grew by 65%. Many of the newly added shareholders know only rising stock markets. Consolidation would not hurt the market. On the other hand, there is hardly any alternative to investing money at the moment. It remains exciting.

Read